Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Neonatal Respiratory Distress Syndrome Treatment Market Expected to Grow Between 2025 And 2029?
The market size of neonatal respiratory distress syndrome treatment has witnessed significant growth in the past few years. The growth is projected to increase from $0.96 billion in 2024 to $1.03 billion in 2025, registering a compound annual growth rate (CAGR) of 7.0%. This growth during the historic period can be attributed to several factors such as the enhanced permeability and fluid accumulation within the alveoli, amplified alveolar-capillary permeability, surging use of mechanical ventilation, heightened awareness amid healthcare providers and parents regarding the crucialness of neonatal care, and escalated healthcare investments.
In the coming years, the market for neonatal respiratory distress syndrome treatment is forecasted to experience significant expansion. The market is predicted to reach $1.39 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%. This growth during the forecast period is due to factors like an elevated inclination towards accessories and consumables, a surge in NICU admissions, the rise in personalized medicine demand, an increase in premature birth phenomena, and augmented research and development activities. The upcoming trends for the forecast period involve the incorporation of automation in neonatal intensive care units (NICUs), integration of artificial intelligence (AI) into systems, advances in neonatal care technology, innovative surfactant therapy, and enhanced ventilator technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp
Which Factors and External Forces Are Driving Demand in the Neonatal Respiratory Distress Syndrome Treatment Market?
The neonatal respiratory distress syndrome treatment market’s growth is anticipated to be fuelled by the escalating prevalence of premature births. Premature birth or preterm birth occurs when a baby is delivered before the 37th week of gestation, with those births occurring before the 32nd week posing the gravest health hazards, considering a typical pregnancy endures about 40 weeks. The surge in premature births can be attributed to reasons like advanced maternal age, multifetal pregnancies, certain health ailments, lifestyle preferences, fertility treatment usage, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) treatment is often necessitated for preterm babies due to their underdeveloped lungs and inadequate surfactant production. This intervention increases lung functionality, normalizes respiration, and diminishes the likelihood of respiratory failure in preterm infants. For instance, Tommy’s, a charity organization based in the UK, stated in December 2022 that the rate of premature live births in England and Wales escalated to 7.9% in 2022 from 7.5% in 2021, marking the second consecutive year of an increase in premature births. Over 53,000 infants were delivered prematurely in 2022. Consequently, the burgeoning occurrence of premature births is propelling the neonatal respiratory distress syndrome treatment market.
Which Segments in the Neonatal Respiratory Distress Syndrome Treatment Offer the Most Growth?
The neonatal respiratory distress syndrome treatmentmarket covered in this report is segmented –
1) By Therapy: Oxygen Therapy; Surfactant Therapy
2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies
Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Neonatal Respiratory Distress Syndrome Treatment Market?# Market?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theNeonatal Respiratory Distress Syndrome Treatment Market’s Growth?
Key industry players in the treatment market for neonatal respiratory distress syndrome are focusing on creating cutting-edge technologies such as nitric oxide generators. These innovations aim to improve oxygenation, reduce respiratory issues and provide non-invasive treatment options for newborns suffering from hypoxic respiratory failure. Medical devices like nitric oxide generators enable the production and administration of nitric oxide gas, typically used to enhance oxygenation and lessen pulmonary hypertension especially in neonates and severely sick patients. For example, Beyond Air Inc., a US-based firm specializing in medical devices and biopharmaceuticals, was granted FDA approval for LungFit PH in June 2022. This state-of-the-art nitric oxide generator is developed to assist term and near-term neonates struggling with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). Leveraging on their proprietary Ionizer technology, the device produces nitric oxide from surrounding air anytime it’s needed, ensuring an unlimited supply without worrying about the dosage or flow. The device uses a low-power compressor to ionize nitrogen and oxygen, subsequently lowering the production of nitrogen dioxide (NO2), which is eventually safely eliminated using a smart filter.
View the full report here:
What Are the Key Elements That Define the Neonatal Respiratory Distress Syndrome Treatment Market?
Neonatal respiratory distress syndrome treatment refers to the management of premature infants with insufficient surfactant production, leading to breathing difficulties. It involves administering exogenous surfactant therapy, providing respiratory support with mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model